Biodistribution of [(68)Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions.

Purpose: The aim of this study was to determine the physiological and pathophysiological biodistribution of [(68)Ga]PSMA-HBED-CC (PSMA-11) ([(68)Ga]PSMA) in patients with prostate cancer (PCA) to establish the range of normal uptake in relevant organs and primary prostate tumours, locally recurrent...

Descripción completa

Detalles Bibliográficos
Publicado en:Molecular Imaging & Biology Vol. 18; no. 3; pp. 428 - 437
Autores principales: Prasad, Vikas, Steffen, Ingo, Diederichs, Gerd, Makowski, Marcus, Wust, Peter, Brenner, Winfried, Steffen, Ingo G, Makowski, Marcus R
Formato: diagnostic images research tables/charts Journal Article
Publicado: Springer Nature Jun2016
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=115398021&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 115398021
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15361632
        KJU
      jtl: Molecular Imaging & Biology
      issn: 15361632
      maglogo: N
    pubinfo:
      dt: Jun2016
      vid: 18
      iid: 3
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        115398021
        115398021
        NLM27038316
        115398021
        10.1007/s11307-016-0945-x
        NLM27038316
        115398021
      ppf: 428
      ppct: 9
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Biodistribution of [(68)Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions.
      aug:
        au:
          Prasad, Vikas
          Steffen, Ingo
          Diederichs, Gerd
          Makowski, Marcus
          Wust, Peter
          Brenner, Winfried
          Steffen, Ingo G
          Makowski, Marcus R
        affil: Department of Nuclear Medicine, Charité Universitätsmedizin Berlin, Augustenburger Platz 1 13353 Berlin Germany
      sug:
        subj:
          Edetic Acid
          Prostatic Neoplasms Pathology
          Prostatic Neoplasms
          Prostate-Specific Antigen Pharmacokinetics
          Aged, 80 and Over
          Neoplasm Metastasis
          Male
          Neoplasm Metastasis Pathology
          ROC Curve
          Middle Age
          Edetic Acid Pharmacokinetics
          Gallium Radioisotopes
          Aged
          Human
          Aged, 80 & over
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
      ab: Purpose: The aim of this study was to determine the physiological and pathophysiological biodistribution of [(68)Ga]PSMA-HBED-CC (PSMA-11) ([(68)Ga]PSMA) in patients with prostate cancer (PCA) to establish the range of normal uptake in relevant organs and primary prostate tumours, locally recurrent PCA, lymph and bone metastases and other metastatic lesions. Additionally, we aimed to determine a cut-off uptake value for differentiation of primary tumours from normal prostate tissue.Procedures: Overall, [(68)Ga]PSMA positron emission tomography/x-ray computed tomography (PET/CT) of 101 patients (mean age 69.1 years) with PCA was analysed retrospectively. For assessment of tracer biodistribution, maximum standardized uptake values (SUVmax) were calculated for various normal organs, as well as for primary tumours (PT) and/or metastases. Results are presented as median, interquartile range (IQR; 25th quantil-75th quantil) and range (minimum-maximum).Results: [(68)Ga]PSMA PET/CT was performed 50 min (range 30-126) after injection of 109 MBq (range 84-158). Regarding biodistribution, highest uptake (median/IQR/range) of the tracer was found in the kidneys (49.6/40.7-57.6/2.7-97.0) followed by the submandibular glands (17.3/13.7-21.2/7.5-30.4), parotid glands (16.1/12.2-19.8/5.5-30.9) and duodenum (13.8/10.5-17.2/5.8-26.9). The best cut-off value for differentiating physiological uptake in the primary tumour from that in the prostate was found to be an SUVmax of 3.2. The median SUVmax in the PT (n = 35), locally recurrent PCA (n = 8), lymph node (n = 166), bone (n = 157) and other metastases (n = 3) were 10.2, 5.9, 6.2, 7.4 and 3.8, respectively. The best cut-off values for differentiating non-pathological uptake in lymph nodes and bones from tumour uptake were found to be SUVmax of 3.2 and 1.9, respectively. Patients with PSA <2 had significantly lower SUVmax in bone metastases as compared to patients with PSA ≥2 (p < 0.01).Conclusions: This biodistribution study provided a broad range of uptake data of [(68)Ga]PSMA-11 for normal organs/tissues, primary prostate tumours and metastatic lesions based on a large patient cohort. Both PT and small metastatic lesions were detectable due to their high tracer uptake. Four-times-higher median uptake in PT in comparison to normal prostate stroma resulted in a high diagnostic accuracy that could potentially be used for multimodal image-guided biopsy with dedicated reconstruction software.
      pubtype: Academic Journal
      doctype:
        diagnostic images
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N